Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays

The use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such as viral diseases. In the case of Hepatitis C, the compounds iopanoic acid and 3,3′,5-triiodothyroacetic acid...

Full description

Bibliographic Details
Main Authors: María San Anselmo, Alexandre Lancelot, Julia E. Egido, Rafael Clavería-Gimeno, Álvaro Casanova, José Luis Serrano, Silvia Hernández-Ainsa, Olga Abian, Teresa Sierra
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/12/11/1062
id doaj-2132957aa4b94befb72330b597c47d4f
record_format Article
spelling doaj-2132957aa4b94befb72330b597c47d4f2020-11-25T04:05:19ZengMDPI AGPharmaceutics1999-49232020-11-01121062106210.3390/pharmaceutics12111062Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-AssaysMaría San Anselmo0Alexandre Lancelot1Julia E. Egido2Rafael Clavería-Gimeno3Álvaro Casanova4José Luis Serrano5Silvia Hernández-Ainsa6Olga Abian7Teresa Sierra8Instituto de Nanociencia y Materiales de Aragón (INMA), University of Zaragoza-CSIC, Pedro Cerbuna 12, 50009 Zaragoza, SpainInstituto de Nanociencia y Materiales de Aragón (INMA), University of Zaragoza-CSIC, Pedro Cerbuna 12, 50009 Zaragoza, SpainInstituto de Nanociencia y Materiales de Aragón (INMA), University of Zaragoza-CSIC, Pedro Cerbuna 12, 50009 Zaragoza, SpainInstituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, SpainDepartamento de Farmacología y Fisiología, Facultad de Medicina, Universidad de Zaragoza, 50009 Zaragoza, SpainInstituto de Nanociencia y Materiales de Aragón (INMA), University of Zaragoza-CSIC, Pedro Cerbuna 12, 50009 Zaragoza, SpainInstituto de Nanociencia y Materiales de Aragón (INMA), University of Zaragoza-CSIC, Pedro Cerbuna 12, 50009 Zaragoza, SpainInstituto Aragonés de Ciencias de la Salud (IACS), 50009 Zaragoza, SpainInstituto de Nanociencia y Materiales de Aragón (INMA), University of Zaragoza-CSIC, Pedro Cerbuna 12, 50009 Zaragoza, SpainThe use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such as viral diseases. In the case of Hepatitis C, the compounds iopanoic acid and 3,3′,5-triiodothyroacetic acid (or tiratricol) were identified in a primary screening as bioactive allosteric inhibitors of viral NS3 protease, but they did not exhibit accurate activity inhibiting viral replication in cell-based assays. In this work, dendritic nanocarriers are proposed due to their unique properties as drug delivery systems to rescue the bioactivity of these two drugs. Specifically, four different amphiphilic Janus dendrimers synthesized by combining 2,2′-<i>bis</i>(hydroxymethyl)propionic acid (<i>bis</i>-MPA) and 2,2′-<i>bis</i>(glyciloxy)propionic acid (<i>bis</i>-GMPA) functionalized with either hydrophilic or lipophilic moieties at their periphery were used to entrap iopanoic acid and tiratricol. Interestingly, differences were found in the loading efficiencies depending on the dendrimer design, which also led to morphological changes of the resulting dendrimer aggregates. The most remarkable results consist of the increased water solubility of the bioactive compounds within the dendrimers and the improved antiviral activity of some of the dendrimer/drug aggregates, considerably improving antiviral activity in comparison to the free drugs. Moreover, imaging studies have been developed in order to elucidate the mechanism of cellular internalization.https://www.mdpi.com/1999-4923/12/11/1062dendrimersmicellar aggregatesself-assemblydrug deliveryhepatitis Cantiviral drug
collection DOAJ
language English
format Article
sources DOAJ
author María San Anselmo
Alexandre Lancelot
Julia E. Egido
Rafael Clavería-Gimeno
Álvaro Casanova
José Luis Serrano
Silvia Hernández-Ainsa
Olga Abian
Teresa Sierra
spellingShingle María San Anselmo
Alexandre Lancelot
Julia E. Egido
Rafael Clavería-Gimeno
Álvaro Casanova
José Luis Serrano
Silvia Hernández-Ainsa
Olga Abian
Teresa Sierra
Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
Pharmaceutics
dendrimers
micellar aggregates
self-assembly
drug delivery
hepatitis C
antiviral drug
author_facet María San Anselmo
Alexandre Lancelot
Julia E. Egido
Rafael Clavería-Gimeno
Álvaro Casanova
José Luis Serrano
Silvia Hernández-Ainsa
Olga Abian
Teresa Sierra
author_sort María San Anselmo
title Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
title_short Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
title_full Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
title_fullStr Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
title_full_unstemmed Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
title_sort janus dendrimers to assess the anti-hcv activity of molecules in cell-assays
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2020-11-01
description The use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such as viral diseases. In the case of Hepatitis C, the compounds iopanoic acid and 3,3′,5-triiodothyroacetic acid (or tiratricol) were identified in a primary screening as bioactive allosteric inhibitors of viral NS3 protease, but they did not exhibit accurate activity inhibiting viral replication in cell-based assays. In this work, dendritic nanocarriers are proposed due to their unique properties as drug delivery systems to rescue the bioactivity of these two drugs. Specifically, four different amphiphilic Janus dendrimers synthesized by combining 2,2′-<i>bis</i>(hydroxymethyl)propionic acid (<i>bis</i>-MPA) and 2,2′-<i>bis</i>(glyciloxy)propionic acid (<i>bis</i>-GMPA) functionalized with either hydrophilic or lipophilic moieties at their periphery were used to entrap iopanoic acid and tiratricol. Interestingly, differences were found in the loading efficiencies depending on the dendrimer design, which also led to morphological changes of the resulting dendrimer aggregates. The most remarkable results consist of the increased water solubility of the bioactive compounds within the dendrimers and the improved antiviral activity of some of the dendrimer/drug aggregates, considerably improving antiviral activity in comparison to the free drugs. Moreover, imaging studies have been developed in order to elucidate the mechanism of cellular internalization.
topic dendrimers
micellar aggregates
self-assembly
drug delivery
hepatitis C
antiviral drug
url https://www.mdpi.com/1999-4923/12/11/1062
work_keys_str_mv AT mariasananselmo janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT alexandrelancelot janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT juliaeegido janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT rafaelclaveriagimeno janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT alvarocasanova janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT joseluisserrano janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT silviahernandezainsa janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT olgaabian janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
AT teresasierra janusdendrimerstoassesstheantihcvactivityofmoleculesincellassays
_version_ 1724434646576398336